Sweden

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. 

We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

Vaccines Sales Specialist and PULSE Volunteer

In Sweden we make a broad range of innovative prescription medicines and vaccines for acute and chronic diseases available for patients. GSK Sweden employs approximately 80 people from a variety of backgrounds, and our office is in Solna. We work with everything from clinical trials and medical collaboration to marketing, sales and various support functions - all to provide Swedish patients and society with needed new medicines and vaccines. We offer an equal and flexible workplace with a culture of care and integrity, where everyone can develop, feel good and thrive regardless of background.

Research and innovation

Innovation is fundamental to us. It helps improve people's health and creates true value. We reinvest a significant proportion of our profits in new research.

We are convinced that collaboration leads to great innovations. We collaborate with healthcare, academia, patient organisations, governments, NGOs and other stakeholders through joint projects, training and by sharing our knowledge.

In Sweden, we conduct clinical research and follow-up studies, known as real world evidence, to develop and evaluate our medicines. We are working to initiate even more research studies, as there is both a need and particularly good circumstances here.

Sustainability and global health

We use our scientific expertise, our partnerships, and our global reach to improve health globally. We contribute to the UN Sustainable Development Goals and Agenda 2030 with various concrete actions. Through our global partnership with Save the Children, we have helped more than three million children.

We have set ambitious, industry leading environmental targets and created solutions that contribute to reducing carbon emissions, plastic consumption, and water impact. GSK Sweden has been a pioneer in reducing the carbon footprint by switching from spray to dry powder in our asthma inhalers. We have also been able to inspire other countries to work towards recommendations that reduce the carbon footprint of asthma inhalers. In addition, we have used innovative solutions to reduce the use of plastic in inhalers and syringes as part of our environmental work.

Careers

We do everything we can to make working at GSK a rewarding experience and to ensure that all employees can be themselves and are supported to thrive and develop. Satisfied and motivated employees who can fulfil their potential are the key to our success. In addition to a wide range of benefits, all employees receive private health insurance, sports and wellbeing support, good parental leave conditions and extra days off, including a so-called Be You day, which each employee can spend as they wish, to bring joy and energy. Our Partnership for Prevention programme gives employees' families or near ones access to free preventive health care.

To find out how you can become part of GSK:

Search for jobs in Sweden

Visit our global LinkedIn page

Contact details

Visiting address

Hemvärnsgatan 9
169 29 Solna

Back to top

Postal address

GlaxoSmithKline AB
Box 516
169 29 Solna
Tel: 08-638 93 00 (switchboard)
Organisation number: 556236-6343

Back to top

Invoice address

GlaxoSmithKline AB
Box 516
169 29 Solna
Email: GSK-Sweden@eportaldoc.com

Back to top

Postal address (Consumer Healthcare)

GSK Consumer Healthcare AB
Hemvärnsgatan 9
17154 Solna
Sweden
Tel: 08-638 43 60
Organisation number: 56767-9880

Back to top

Reporting an adverse event

If you want to report a side effect on any of our medicines or vaccines, you can contact us as follows:

Tel: 08-638 93 00 (ask to be connected to the Side Effects Unit)

Use our web form

In order to be able to handle your request, complaint or side effect report, it is required that GlaxoSmithKline AB and / or GlaxoSmithKline Consumer Healthcare AB register and handle the personal data that you have provided to us. This may include your name, last name, contact information, as well as any information that relates to your health and that you have provided to us. This personal data will only be processed for the purpose of handling your request, complaint or side effect report. Read more detailed information regarding the processing of your personal data.

Back to top

Medical information and questions about our medicines and vaccines

For medical questions about our medicines and vaccines, healthcare professionals can contact our medical information where specialists answer questions in Scandinavian and English. As a pharmaceutical company we cannot give medical advice to patients or dependants. Please contact your GP or local pharmacy.

Email: info.produkt@gsk.com (for HCPs only)
Tel: 08-638 93 00

Back to top

Media enquiries

For press releases - visit GSK's press room on MyNewsdesk. Please note that the press room is for journalists only.

Communication Manager, Pharma

Maria Ericson
Tel: +46 0730335969
Email: maria.b.ericson@gsk.com

Communications Manager Consumer Healthcare

Barbara Powell
Tel: +46 709 526 725

Back to top

Healthcare professionals and patient groups

Healthcare professionals

Healthcare professionals in Sweden can obtain information about products and therapy areas related to GSK by visiting GSKPro.

Collaboration with health professionals and health organisations

The European Federation of Pharmaceutical Industries and Associations (EFPIA), of which the Association of the Pharmaceutical Industry in Sweden (LIF) is a member, has been at the forefront of announcing all financial transfers to healthcare professionals since 2015.
From the beginning, GSK has had full transparency about all payments.

Go to the full EFPIA report and read more

Back to top

Patient group funding

Back to top